Deyali Chatterjee Selected Research

Deyali Chatterjee Research Topics

Disease

33	Neoplasms (Cancer) 05/2024 - 01/2012
23	Adenocarcinoma 06/2023 - 03/2012
7	Pancreatic Neoplasms (Pancreatic Cancer) 12/2022 - 04/2014
4	Neoplasm Metastasis (Metastasis) 01/2023 - 09/2015
4	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2023 - 01/2017
3	Lymphatic Metastasis 05/2023 - 01/2015
3	Residual Neoplasm 12/2022 - 06/2012
3	Lung Neoplasms (Lung Cancer) 02/2019 - 08/2012
2	Hyperplasia 01/2023 - 01/2022
2	Microsatellite Instability 06/2022 - 01/2021
2	Insulinoma 10/2020 - 10/2019
2	Fibrosis (Cirrhosis) 01/2020 - 12/2013
2	Carcinoma (Carcinomatosis) 01/2019 - 06/2012
2	Inflammation (Inflammations) 01/2017 - 12/2013
2	Carcinogenesis 12/2013 - 02/2013
1	Candidiasis (Moniliasis) 05/2024
1	Esophageal Diseases 05/2024
1	Necrosis 06/2023
1	Acute Cholecystitis 06/2023
1	Hemorrhage 06/2023
1	Leukoencephalopathies 01/2023
1	Neuroendocrine Carcinoma 01/2023
1	Ascites 01/2023
1	Pancreaticobiliary Maljunction 09/2022
1	Carcinoma in Situ 09/2022
1	Abdominal Pain (Pain, Abdominal) 09/2022
1	Choledochal Cyst (Choledochal Cysts) 09/2022
1	Sclerosing Cholangitis 09/2022
1	Parasitic Diseases (Parasitic Disease) 09/2022
1	Glandular and Epithelial Neoplasms (Neoplasms, Glandular) 09/2022
1	Rectal Neoplasms (Rectal Cancer) 07/2021
1	Sarcoidosis (Schaumann Disease) 01/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2021
1	Pathologic Complete Response 04/2020
1	Tics (Tic) 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 11/2019
1	Chemical and Drug Induced Liver Injury 02/2019
1	Adenocarcinoma of Lung 02/2019
1	Cholecystitis 01/2019
1	Non-alcoholic Fatty Liver Disease 01/2019
1	Prostatic Neoplasms (Prostate Cancer) 06/2015
1	Disease Progression 12/2014
1	Hypoxia (Hypoxemia) 12/2014

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 10/2020 - 08/2012
4	N-acetyltalosaminuronic acid (NAT)IBA 06/2023 - 11/2018
3	Gemcitabine FDA Link 05/2023 - 04/2014
2	Eosine Yellowish-(YS) (Eosin)IBA 12/2022 - 01/2019
2	Dental Porcelain (Porcelain)IBA 09/2022 - 01/2019
2	SynaptophysinIBA 01/2021 - 10/2019
2	Transcription Factors (Transcription Factor)IBA 10/2020 - 10/2019
2	ErbB Receptors (EGF Receptor)IBA 02/2019 - 09/2015
2	LumicanIBA 10/2016 - 12/2014
2	DNA (Deoxyribonucleic Acid)IBA 11/2014 - 04/2014
1	Fluconazole (Zonal)FDA LinkGeneric 05/2024
1	AzolesIBA 05/2024
1	trans-sodium crocetinate (crocetin)IBA 08/2023
1	130-nm albumin-bound paclitaxelIBA 05/2023
1	folfirinoxIBA 05/2023
1	Retinaldehyde (Retinal)IBA 01/2023
1	Alkaline PhosphataseIBA 01/2023
1	Exonucleases (3' 5' Exonuclease)IBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	NectinsIBA 01/2022
1	Proton Pump InhibitorsIBA 01/2022
1	ChromograninsIBA 01/2021
1	Hemoglobins (Hemoglobin)IBA 11/2019
1	RadonIBA 11/2019
1	Chromogranin AIBA 10/2019
1	Tyrosine Kinase InhibitorsIBA 02/2019
1	osimertinibIBA 02/2019
1	Hematoxylin (Haematoxylon)IBA 01/2019
1	Bile Acids and Salts (Bile Acids)IBA 01/2019
1	Lipocalin-2IBA 01/2017
1	CollagenIBA 10/2016
1	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2016
1	Capecitabine (Xeloda)FDA Link 01/2016
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2016
1	Bevacizumab (Avastin)FDA Link 01/2016
1	AT 61IBA 01/2016
1	Somatomedin Receptors (Somatomedin Receptor)IBA 09/2015
1	Coal (Coals)IBA 01/2015
1	Glucose (Dextrose)FDA LinkGeneric 12/2014
1	Lactic Acid (Lactate)FDA LinkGeneric 12/2014
1	Adenosine Triphosphate (ATP)IBA 12/2014
1	Cyclin D1IBA 05/2014
1	Nucleoside Transport Proteins (Nucleoside Transporter)IBA 04/2014
1	Phosphotransferases (Kinase)IBA 12/2013
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 12/2013
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 11/2013
1	TensinsIBA 11/2013

Therapy/Procedure

13	Neoadjuvant Therapy 06/2023 - 04/2012
12	Therapeutics 05/2023 - 11/2014
8	Pancreaticoduodenectomy 06/2023 - 03/2012
4	Cholecystectomy 06/2023 - 01/2019
3	Immunotherapy 06/2022 - 01/2021
2	Pancreatectomy 05/2023 - 01/2020
2	Drug Therapy (Chemotherapy) 11/2018 - 04/2014
1	Colectomy 10/2021
1	Adjuvant Chemotherapy 10/2021
1	Radiotherapy 01/2016